Harvey Investment Co LLC has disclosed its latest holdings in a 13F-HR report, revealing a total of 101 holdings valued at approximately $925.7 million as of September 30, 2026. This filing is significant as it provides insights into the company's investment strategies and portfolio adjustments.
Harvey Investment Co LLC, incorporated in Delaware, operates as an asset management firm. The company is known for its strategic investments across various sectors. Its recent filings include multiple 13F-HR reports, with the latest dated October 20, 2026, and previous filings on August 7 and July 22, 2026.
The recent filing indicates that the firm has maintained a diverse investment portfolio, with notable stakes in companies such as 3M Company, Abbott Labs, and AbbVie Inc. The report highlights an investment discretion of "DFND," indicating that Harvey Investment Co LLC has full discretion over its investments. The filing also notes the voting authority for each holding, providing further transparency into the firm's investment practices.
This update may impact various stakeholders, including investors, analysts, and competitors within the asset management industry. The reported holdings reflect not only Harvey Investment Co's investment philosophy but also its response to market conditions and opportunities.
Looking ahead, the filing does not specify any upcoming actions or changes in strategy. However, the ongoing monitoring of market trends and investment performance will likely influence future filings and investment decisions.